This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for RPRD1B? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the RPRD1B IHC GuideFacts about Regulation of nuclear pre-mRNA domain-containing protein 1B.
Promotes binding of RNA polymerase II into the CCDN1 promoter and to the termination area before the poly-A site but decreases its binding following the poly-A site. Prevents RNA polymerase II from reading through the 3' end termination site and may let it be recruited back to the promoter through promotion of the formation of a chromatin loop.
| Human | |
|---|---|
| Gene Name: | RPRD1B |
| Uniprot: | Q9NQG5 |
| Entrez: | 58490 |

| Belongs to: |
|---|
| UPF0400 (RTT103) family |

Cell cycle-related and expression-elevated protein in tumor; cell-cycle related and expression-elevated protein in tumor; chromosome 20 open reading frame 77; CREPTC20orf77; dJ1057B20.2; DKFZp434P0735; FLJ44520; NET60; regulation of nuclear pre-mRNA domain containing 1B; regulation of nuclear pre-mRNA domain-containing protein 1B
Mass (kDA):
36.9 kDA

| Human | |
|---|---|
| Location: | 20q11.23 |
| Sequence: | 20; NC_000020.11 (38033462..38092366) |
Preferentially expressed in a range of tumor tissues including colon, lung, liver, breast, prostate, stomach, uterine endometrium and cervical cancers with higher levels in tumors than in adjacent non-tumor tissue (at protein level).
Nucleus.



PMID: 22264791 by Lu D., et al. CREPT accelerates tumorigenesis by regulating the transcription of cell-cycle-related genes.
PMID: 22231121 by Ni Z., et al. Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B.